NCT01002911View on ClinicalTrials.gov

Prevention of Arrhythmia Device Infection Trial (PADIT Pilot)

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Arrythmias
Interventions
DRUG

Cefazolin, Bacitracin, Cefalexin

Single does of Cefazolin 1-2 g iv given over 60-120 minutes, 60-120 minutes prior to skin incision, Bacitracin wash, Cefalexin 250-500 mg TID

DRUG

Cefazolin

Cefazolin 1-2 g iv given over 60-120 minutes, 60-120 minutes prior to skin incision

Trial Locations (1)

G1V 4G5

Institut universitaire de cardiologie et de pneumologie de Quebec, Ste-Foy

Sponsors
All Listed Sponsors
lead

Population Health Research Institute

OTHER